Login
$KALA
$3.77 -$0.06 (1.56%) After hours

$KALA SEC Filings

Filed On Filing
13 Nov 2026 NT 10-Q
12 Nov 2026 8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more

Arlington, MA, November 12, 2026 (GLOBE NEWSWIRE) — KALA BIO, Inc. (NASDAQ: KALA) (“KALA BIO” or the “Company”), today announced that it intends to effect a reverse stock split of its common stock, par value $0.001 per share (the “common...

09 Nov 2026 8-K: Results of Operations and Financial Condition

New York, November 9, 2026 – KALA BIO, Inc. (Nasdaq: KALA) today announced preliminary unaudited financial results for the quarter ended September 30, 2026.

03 Nov 2026 8-K: Submission of Matters to a Vote of Security Holders

A total of 14,459,767 shares of the Company’s Common Stock were present in person or represented by proxy at the Annual Meeting. At the Annual Meeting, stockholders voted in favor of the following items of business:

19 Oct 2026 SCHEDULE 13G
24 Sep 2026 Proxy statement: annual meeting on November 3, 2026

CEO pay $907K, down 39% · say-on-pay vote

11 Sep 2026 PRE 14A
10 Sep 2026 8-K: Entry into a Material Definitive Agreement

CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN EXCLUDED FROM THIS DOCUMENT BECAUSE IT IS BOTH (A) NOT MATERIAL AND (B) THE TYPE OF INFORMATION THAT THE COMPANY CUSTOMARILY AND ACTUALLY TREATS AS PRIVATE AND CONFIDENTIAL.

09 Sep 2026 8-K: Shareholder Director Nominations; Other Events

To the extent applicable, the information set forth below under Item 8.01 of this Current Report on Form 8-K is incorporated by reference into this Item 5.08.

28 Aug 2026 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

19 Aug 2026 10-Q
14 Aug 2026 NT 10-Q
23 Jul 2026 8-K: Other Events

Registration Statement on Form S-3, Registration No. 333-295667

22 Jul 2026 424B5
02 Jul 2026 SCHEDULE 13D/A
25 Jun 2026 EFFECT
12 Jun 2026 S-3/A
15 May 2026 SCHEDULE 13G/A
15 May 2026 10-Q
07 May 2026 S-3

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support